The bone morphogenetic protein I/Tolloid-like metalloproteinases

被引:195
作者
Hopkins, Delana R.
Keles, Sunduz
Greenspan, Daniel S.
机构
[1] Univ Wisconsin, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Stat Biostat & Med Informat, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA
[4] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA
关键词
BMP1; procollagen; extracellular matrix; tolloid; metalloproteinases; TGF beta;
D O I
10.1016/j.matbio.2007.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A decade ago, bone morphogenetic protein 1 (BMP1) was shown to provide the activity necessary for proteolytic removal of the C-propeptides of procollagens I-III: precursors of the major fibrillar collagens. Subsequent studies have shown BMP1 to be the prototype of a small group of extracellular metalloproteinases that play manifold roles in regulating formation of the extracellular matrix (ECM). Soon after initial cloning of BMP1, genetic studies showed the related Drosophila proteinase Tolloid (TLD) to be necessary for the formation of the dorsal-ventral axis in early embryogenesis. It is now clear that the BMP1/TLD-like protemases, conserved in species ranging from Drosophila to humans, act in dorsal-ventral patterning via activation of transforming growth factor beta (TGF beta)-like proteins BMP2, BMP4 (vertebrates) and decapentaplegic (arthropods). More recently, it has become apparent that the BMP1/TLD-like protemases are activators of a broader subset of the TGF beta superfamily of proteins, with implications that these protemases may be key in orchestrating the fort-nation of ECM with growth factor activation and BMP signaling in morphogenetic processes. (c) 2007 Elsevier B.V./International Society of Matrix Biology. All rights reserved.
引用
收藏
页码:508 / 523
页数:16
相关论文
共 178 条
[1]   Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 γ2 chain [J].
Amano, S ;
Scott, IC ;
Takahara, K ;
Koch, M ;
Champliaud, MF ;
Gerecke, DR ;
Keene, DR ;
Hudson, DL ;
Nishiyama, T ;
Lee, S ;
Greenspan, DS ;
Burgeson, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :22728-22735
[2]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[3]  
[Anonymous], 1994, EXTRACELLULAR MATRIX
[4]  
[Anonymous], 1993, Resampling-based multiple testing: Examples and methods for P-value adjustment
[5]  
[Anonymous], STRUCTURE FUNCTION C
[6]   The deletion of transforming growth factor-β-induced myofibroblasts depends on growth conditions and actin organization [J].
Arora, PD ;
McCulloch, CAG .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :2087-2099
[7]   Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[8]   EXPRESSION AND LOCALIZATION OF THE 2 SMALL PROTEOGLYCANS BIGLYCAN AND DECORIN IN DEVELOPING HUMAN SKELETAL AND NONSKELETAL TISSUES [J].
BIANCO, P ;
FISHER, LW ;
YOUNG, MF ;
TERMINE, JD ;
ROBEY, PG .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (11) :1549-1563
[9]   EXTRACELLULAR COMPARTMENTS IN MATRIX MORPHOGENESIS - COLLAGEN FIBRIL, BUNDLE, AND LAMELLAR FORMATION BY CORNEAL FIBROBLASTS [J].
BIRK, DE ;
TRELSTAD, RL .
JOURNAL OF CELL BIOLOGY, 1984, 99 (06) :2024-2033
[10]  
BIRK DE, 1990, J CELL SCI, V95, P649